These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30986824)

  • 21. Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin.
    El-Khamisy SF; Katyal S; Patel P; Ju L; McKinnon PJ; Caldecott KW
    DNA Repair (Amst); 2009 Jun; 8(6):760-6. PubMed ID: 19303373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete APTX deletion in a patient with ataxia with oculomotor apraxia type 1.
    van Minkelen R; Guitart M; Escofet C; Yoon G; Elfferich P; Bolman GM; van der Helm R; van de Graaf R; van den Ouweland AM
    BMC Med Genet; 2015 Aug; 16():61. PubMed ID: 26285866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Who and how in the regulation of mitochondrial cristae shape and function.
    Quintana-Cabrera R; Mehrotra A; Rigoni G; Soriano ME
    Biochem Biophys Res Commun; 2018 May; 500(1):94-101. PubMed ID: 28438601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of APTX nicked DNA sensing and pleiotropic inactivation in neurodegenerative disease.
    Tumbale P; Schellenberg MJ; Mueller GA; Fairweather E; Watson M; Little JN; Krahn J; Waddell I; London RE; Williams RS
    EMBO J; 2018 Jul; 37(14):. PubMed ID: 29934293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a pathogenic mutation of SOD1 sensitizes aprataxin-deficient cells and mice to oxidative stress and triggers hallmarks of premature ageing.
    Carroll J; Page TK; Chiang SC; Kalmar B; Bode D; Greensmith L; Mckinnon PJ; Thorpe JR; Hafezparast M; El-Khamisy SF
    Hum Mol Genet; 2015 Feb; 24(3):828-40. PubMed ID: 25274775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation of aprataxin associated with ataxia ocular apraxia type 1: phenotypical and genotypical characterization.
    Ferrarini M; Squintani G; Cavallaro T; Ferrari S; Rizzuto N; Fabrizi GM
    J Neurol Sci; 2007 Sep; 260(1-2):219-24. PubMed ID: 17572444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients.
    Castellotti B; Mariotti C; Rimoldi M; Fancellu R; Plumari M; Caimi S; Uziel G; Nardocci N; Moroni I; Zorzi G; Pareyson D; Di Bella D; Di Donato S; Taroni F; Gellera C
    Neurogenetics; 2011 Aug; 12(3):193-201. PubMed ID: 21465257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy.
    Mayorov VI; Lowrey AJ; Biousse V; Newman NJ; Cline SD; Brown MD
    BMC Biochem; 2008 Sep; 9():22. PubMed ID: 18783614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex Movement Disorders in Ataxia with Oculomotor Apraxia Type 1: Beyond the Cerebellar Syndrome.
    Pedroso JL; Vale TC; da Costa SCG; Santos M; Alonso I; Barsottini OGP
    Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():39. PubMed ID: 33101765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
    Mancini C; Hoxha E; Iommarini L; Brussino A; Richter U; Montarolo F; Cagnoli C; Parolisi R; Gondor Morosini DI; Nicolò V; Maltecca F; Muratori L; Ronchi G; Geuna S; Arnaboldi F; Donetti E; Giorgio E; Cavalieri S; Di Gregorio E; Pozzi E; Ferrero M; Riberi E; Casari G; Altruda F; Turco E; Gasparre G; Battersby BJ; Porcelli AM; Ferrero E; Brusco A; Tempia F
    Neurobiol Dis; 2019 Apr; 124():14-28. PubMed ID: 30389403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired OMA1-dependent cleavage of OPA1 and reduced DRP1 fission activity combine to prevent mitophagy in cells that are dependent on oxidative phosphorylation.
    MacVicar TD; Lane JD
    J Cell Sci; 2014 May; 127(Pt 10):2313-25. PubMed ID: 24634514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.
    Liao C; Ashley N; Diot A; Morten K; Phadwal K; Williams A; Fearnley I; Rosser L; Lowndes J; Fratter C; Ferguson DJ; Vay L; Quaghebeur G; Moroni I; Bianchi S; Lamperti C; Downes SM; Sitarz KS; Flannery PJ; Carver J; Dombi E; East D; Laura M; Reilly MM; Mortiboys H; Prevo R; Campanella M; Daniels MJ; Zeviani M; Yu-Wai-Man P; Simon AK; Votruba M; Poulton J
    Neurology; 2017 Jan; 88(2):131-142. PubMed ID: 27974645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
    Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
    PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aprataxin (APTX) gene mutations resembling multiple system atrophy.
    Baba Y; Uitti RJ; Boylan KB; Uehara Y; Yamada T; Farrer MJ; Couchon E; Batish SD; Wszolek ZK
    Parkinsonism Relat Disord; 2007 Apr; 13(3):139-42. PubMed ID: 17049295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aprataxin, a novel protein that protects against genotoxic stress.
    Gueven N; Becherel OJ; Kijas AW; Chen P; Howe O; Rudolph JH; Gatti R; Date H; Onodera O; Taucher-Scholz G; Lavin MF
    Hum Mol Genet; 2004 May; 13(10):1081-93. PubMed ID: 15044383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aprataxin localizes to mitochondria and preserves mitochondrial function.
    Sykora P; Croteau DL; Bohr VA; Wilson DM
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7437-42. PubMed ID: 21502511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short half-lives of ataxia-associated aprataxin proteins in neuronal cells.
    Hirano M; Asai H; Kiriyama T; Furiya Y; Iwamoto T; Nishiwaki T; Yamamoto A; Mori T; Ueno S
    Neurosci Lett; 2007 May; 419(2):184-7. PubMed ID: 17485165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation.
    Quinzii CM; Kattah AG; Naini A; Akman HO; Mootha VK; DiMauro S; Hirano M
    Neurology; 2005 Feb; 64(3):539-41. PubMed ID: 15699391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actions of aprataxin in multiple DNA repair pathways.
    Rass U; Ahel I; West SC
    J Biol Chem; 2007 Mar; 282(13):9469-9474. PubMed ID: 17276982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar localization of aprataxin is dependent on interaction with nucleolin and on active ribosomal DNA transcription.
    Becherel OJ; Gueven N; Birrell GW; Schreiber V; Suraweera A; Jakob B; Taucher-Scholz G; Lavin MF
    Hum Mol Genet; 2006 Jul; 15(14):2239-49. PubMed ID: 16777843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.